MeSH tree: D27.505.696.422.125
For many people living with obesity, Wegovy and Mounjaro offer the possibility of substantial weight loss without surgery. Yet data from one private provider points to a troubling divide: Prescription rates of these drugs ...
Sep 9, 2026
0
6
The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain. The study was led by Chloe ...
Sep 7, 2026
0
13
Although the number of U.S. children under age 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and Zepbound remains low, it was 310 times higher in June 2026 than in 2019, when the drugs were first ...
Sep 4, 2026
0
19
Employer health care costs are on track to climb about 11% next year, the sharpest jump in more than two decades.
Sep 3, 2026
0
5
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that, among currently ...
Sep 1, 2026
0
19
There is no link between the widely used diabetes and obesity medications known as GLP-1 receptor agonists and increased suicidal thoughts, depression or other serious psychiatric harm, based on an integrative review of current ...
Aug 31, 2026
0
17
Glucagon-like peptide 1 receptor agonists (GLP-1RA), commonly used to treat diabetes and weight loss, may have additional mental health benefits, especially for people with bipolar disorder, new Griffith University research ...
Aug 24, 2026
0
17
Researchers surveyed 114 sports medicine physicians from 38 countries, covering 93 different sports, to explore their views on athletes' use of GLP-1 drugs. Twelve percent said they were aware of athletes using the medications ...
Aug 20, 2026
0
12
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...
Aug 16, 2026
0
9
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and ...
Aug 14, 2026
0
1569
